LIXT vs RNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 13, 2026

LIXT

45.1
AI Score
VS
RNA Wins

RNA

45.6
AI Score

Investment Advisor Scores

LIXT

45score
Recommendation
HOLD

RNA

46score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric LIXT RNA Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% 1148.3% RNA
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 45.1/100 45.6/100 RNA
Profit Margin 0.0% -160.0% LIXT
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

LIXT 1M: +2.4% · 3M: +135.2% RNA 1M: +10.8% · 3M: +1.2%

Current Technical Phase

LIXT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (38.2% over 20 days), RSI 54

RSI (14): 54.4 · Price: $7.21

RNA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 61

RSI (14): 60.7 · Price: $13.20

Fundamentals Snapshot

Metric LIXT RNA
Market Cap
Forward P/E 0.0 -2.1
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 11.5%
Gross Margin -0.3%
Operating Margin 0.0% -0.9%
EPS -1.15 -4.98
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, RNA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.